To identify factors associated with ST-segment myocardial infarction (STEMI) patients who had no chest pain, and to improve recognition of STEMI patients without presentation of chest pain in the emergency department (ED 
Introduction
ST-segment elevation myocardial infarction (STEMI) is a lethal disease usually diagnosed in the emergency department (ED). Prompt recognition and treatment can improve outcome and mortality. According to the ACC/AHA guidelines for the management of STEMI, a 12-lead electrocardiogram (ECG) should be obtained and interpreted within 10 minutes of arrival, and primary percutaneous intervention is recommended within 90 minutes as a system's goal when patients presented with symptoms within 12 hours. 1, 2 Clinically, STEMI is suspected based on a patient's presentations and an ECG will be ordered for confirmation. A previous study of 8,885 ED visits showed that only 40.9% of STEMI patients had an ECG within 10 minutes of arrival, and an increased risk of adverse clinical outcomes was related to the delay of ECG. 3 Atypical presentations in STEMI can cause delay of ECG exam and subsequent reperfusion, 4, 5 especially in patients who had no chest pain in their chief complaints. However, the absence of chest pain does not exclude STEMI in the ED.
Limited studies were related to STEMI patients without chest pain in ED when we reviewed literatures. Thus, we conducted a retrospective study which focused on atypical presentations in STEMI patients, and compared clinical features between patients with and without chest pain. The primary purpose of our study was to identify risk factors of STEMI patients without chest pain in order to improve recognition of STEMI patients without chest pain in ED.
Method

Study design and data collection
We conducted a retrospective observational study in a 1000-bed university-affiliated general hospital in south-central Taiwan. 
Methods and data analysis
Differences in patient demographics, clinical characteristics, and hospital management and outcomes between patients presenting without chest pain and those with chest pain were assessed using the Chi-square test or the Fisher exact test for categorical variables (expressed as frequencies and percentages), and the Mann Whitney U test or a Student's t test for continuous variables without normal distribution or with normal distribution. The difference was considered significant if the p value is smaller than 0.05. Multiple logistic regression was used to examine the association between patient demographics and symptoms without chest pain of STEMI adjusting for factors associated with p<0.25 on univariate analysis. These included the following: age, sex, diabetes mellitus (DM), history of cerebrovascular accident (CVA), and smoking in the past year. Statistical analysis was carried out using the software SPSS 14.0 (SPSS Inc, Chicago, IL).
Results
We enrolled 260 STEMI patients from 2006 to 2009. Chest pain was presented in 87.3% of all symptoms and 12.7% of STEMI patients had no chest pain in their symptoms in the ED. Clinical symptoms other than chest pain included syncope (9.2%), epigastric pain (6.9%), dyspnoea (34.2%), general weakness, dizziness, cold sweating, nausea and vomiting, and back pain (Table 1) . Syncope, epigastric pain, and dyspnoea were the three major symptoms in STEMI patients without chest pain in the ED (Table 2) .
Patients without chest pain were significantly older than those with typical symptoms. They were more (A) likely to be women and to have a history of diabetes and cerebrovascular accidents but less likely to have a history of smoking in the past year. In hospital management, the difference in performance of percutaneous coronary intervention between patients without chest pain and patients with chest pain was significant. STEMI patients without chest pain were less likely to receive primary percutaneous coronary intervention (p<0.001). In the results, STEMI patients without chest pain had more complications of congestive heart failure (Killip class IV) and higher 30-day mortality. The risk factors of presentations without chest pain in STEMI patients were DM, CVA, and old age (Table 4 ).
Discussion
Our study demonstrated the atypical symptoms in STEMI patients in the ED, in a population of Asians in south-central Taiwan. The atypical presentations of acute coronary syndrome (ACS) had been addressed in previous publications. 6, 7 However, the subgroup of STEMI patients presenting other than chest pain had seldom been discussed. In our study, STEMI patients without chest pain were more likely to have a history of DM and CVA, to be a nonsmoker, a female, or elderly. Multivariate analysis revealed that DM, CVA, and old age were risk factors for STEMI patients without chest pain.
In a previous study, 8.4% of patients presented without chest pain in ACS. 6 Another study showed that only 53% of patients presented with chest pain in ACS. 7 The frequency of other complaints were dyspnoea (17%), cardiac arrest (7%), dizziness/weakness/syncope (4%), and abdominal pain (2%). According to our results, there were 12.7% of STEMI patients who had no chest pain in their symptoms in the ED. Syncope, epigastric pain, and dyspnoea were the three major symptoms of STEMI patients without chest pain. Patients presenting with syncope, epigastric pain, and dyspnoea could be mistaken and managed as patients with diseases other than STEMI, such as transient ischaemic attack, acute gastritis, biliary colic, and lung diseases. Other symptoms included general weakness, dizziness, cold sweating, nausea and vomiting, and back pain. Those non-specific symptoms usually challenged doctors in approaching patients in the ED. Patients without chest pain could be mistaken to have diseases other than STEMI, and were managed and discharged with misdiagnosis.
Female and old patients were prone to have presentations other than a typical chest pain. In a study conducted in Middle Eastern countries, ischaemic chest pain at presentation was more evident in men (men vs. women: 82% vs. 71%, p<0.01), while women presented more frequently with dyspnoea and atypical chest pain in ACS. 8 The result corresponded to another study in America. 9 In the elderly (>75 years old), dyspnoea, fatigue, and other heart failure symptoms were more frequently the first symptoms of acute myocardial infarction (AMI) than a typical chest pain (p<0.05). 10 In underlying diseases in ACS patients, women and elderly patients had a significantly higher prevalence of DM, HTN, and CVA. [8] [9] [10] The differences in peripheral vascular disease, heart failure, and myocardial infarction had conflicts in different studies. In our study, women accounted for 45.5% of patients without chest pain in STEMI, and patients were 9 years older than patients without chest pain (74.3±10.0 vs. 65.0±12.6, p<0.001, Table 3 ). The result corresponded to previous studies, which showed significant gender and age differences between typical and atypical symptoms of ACS. In underlying diseases, patients with DM and CVA had a higher risk of presenting with symptoms other than chest pain. Our study had different results from another study on STEMI; Thuresson noted differences between age groups were minor and there was no difference between patients with and without diabetes.
11
Cigarette smoking was significantly less common among women and elderly patients in ACS. 9, 10 This was consistent with STEMI patients without chest pain in our study. In our study, none of the women smoked and in Taiwan, only 5.23% of women are smokers. 12 Differences also existed in the management of STEMI patients with and without chest pain. The absence of chest pain was associated with failure to receive reperfusion therapy in patients without chest pain. 5 In the GRACE study, 58% of patients without chest pain but with significant ST-segment elevation did not receive reperfusion therapy (without chest pain vs. with chest pain, odds ratio: 3.57, p<0.0001). 13 STEMI patients without chest pain could misunderstand their symptoms and go to the ED more than twelve hours after onset of the symptoms, and thus miss opportunities for reperfusion therapy. The absence of chest pain also significantly lengthened door-to-balloon time in reperfusion.
14 In our report, 30% of patients without chest pain in all symptoms did not receive catheterisation in the ED and after admission. Patients without chest pain, even if they had an ECG with ST elevation, were more likely to be managed with conservative treatment. STEMI patients without chest pain were older and were less likely to receive reperfusion therapy. 13 The association between duration of symptoms, onset of symptoms, and reperfusion therapy in STEMI patients without chest pain needs further investigations.
The limitation of our study included small study sample size and possible medical record errors in a retrospective design. The associated symptoms taken in the ED depended on the primary care physician. A crowded ED could make the doctors rush their history taking and then miss associated symptoms.
Conclusions
In our study, DM, CVA, and old age are associated with STEMI patients without chest pain. The result alerts the ED doctors to pay attention to patients without chest pain and with clinical features of higher risk in STEMI. An ECG may be needed to exclude STEMI when ED doctors approach a patient with symptoms of syncope, epigastric pain, and dyspnoea and with risk factors of DM, CVA, and old age.
